Article Archive

Dr. Bertram Lubin Named CEO of Children's Hospital & Research Center Oakland

Issue: September 2009

Bertram Lubin, M.D., has been named president and chief executive officer of Children’s Hospital & Research Center Oakland. Dr. Lubin replaces Frank Tiedemann, who was president and CEO since early 2005.

“The Board wishes to express its gratitude and appreciation for Frank Tiedemann’s conscientious dedication and service,” said Harold Davis, chair of the Board of Directors of Children’s Hospital & Research Center Oakland. “Frank’s collaboration and vigorous pursuit of our objectives have been important to the communities we serve in these difficult financial times.”

Dr. Lubin is the hospital’s Senior Vice President, Research, and President and Director of Medical Research for the hospital’s research arm, Children's Hospital Oakland Research Institute. He has been at Children’s since 1971. As CEO, he will direct an organization with more than 2,600 employees including 200 doctors, and an annual budget of more than $300 million.

Dr. Lubin began development of the hospital's Sickle Cell Screening, Counseling and Education Program, the Northern California Comprehensive Sickle Cell Center and the Sibling Donor Cord Blood Program, and has been a driving force and catalyst in the expansion and development of basic and clinical research at Children's. Under his leadership, Children's Hospital Oakland Research Institute now manages a budget of more than $50 million, has more than 300 research and support staff and ranks sixth in National Institutes of Health funding to children's hospitals in the nation.

Dr. Lubin is an adjunct professor of pediatrics at the University of California, San Francisco, has served on dozens of professional and governmental commissions and committees, lists more than 150 medical/scientific publications, and has written several books and chapters related to hematology.

Back to Article Archive